Search results
FDA advisory panel recommends new Alzheimer's drug after scrutiny
UPI· 3 days agoA U.S. Food and Drug Administration advisory panel voted unanimously on Monday to recommend that the...
Hospitalizations, ER visits quickly rising in Hawaii due to COVID
Tribune via AOL· 7 days agoThe numbers of emergency room visits and patients hospitalized for COVID-19 have been increasing at an accelerating pace in Hawaii. On Wednesday the state ...
Group proposes new definition of long COVID
UPI· 3 days agoLong COVID is a chronic condition that occurs after COVID-19 infection and is present for at least three months, the new< ...
National Academies Issue New Broad Definition of Long COVID
Medscape· 3 days agoA new broadly inclusive definition of long COVID from the National Academies of Sciences,...
2-in-1 shot for flu and COVID shows promise in advanced trial
Live Science via Yahoo News· 4 days agoThe...headaches. These side effects also show up with existing COVID-19 and flu vaccines. However,...
Revive Therapeutics Provides Update on FDA Type C Meeting for Clinical Study of Bucillamine to Treat...
Digital Journal· 2 days agoThe FDA has recommended that the evaluation of Bucillamine for Long COVID be submitted as a new Investigational New
Donanemab’s solid day
Politico· 3 days agoMODERNA: COMBO FLU-COVID SHOT SHOWS PROMISE — A dual shot for flu and Covid-19 had a higher immune response than vaccines on the market ...
Solving RLS: Largest Genetic Study to Date May Help
Medscape· 6 hours agoFor decades, scientists have been trying to unravel the mysteries of restless legs syndrome (RLS), a poorly understood and underdiagnosed neurological...
Newer Therapies Target Different Melasma Components
Medscape· 2 days agoThe pathogenesis of melasma is complex, with genetic, hormonal, and other components that may play a role when choosing treatments, Nada Elbuluk, MD,...
New Oral Antibiotic Works Against Drug-Resistant Gonorrhea
Medscape· 4 days agoA first-in-class antibiotic zoliflodacin is non-inferior to standard of care (SOC) in the treatment...